Precision Biosensor, Inc.

Equities

A335810

KR7335810008

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 03:30:00 24/05/2024 am IST			5-day change	1st Jan Change
4,250 ^KRW	+1.19%		-0.70%	-10.90%

25/03	Qlife Signs Letter of Intent with Precision Biosensor	CI
08/02	Precision Biosensor, Inc. announced that it has received KRW 3 billion in funding from Shinhan Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd.	CI

Precision Biosensor, Inc. has completed an IPO in the amount of KRW 18.75 billion.

December 16, 2020 at 10:30 am IST

Precision Biosensor, Inc. has completed an IPO in the amount of KRW 18.75 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,500,000 PriceRange: KRW 12500 Discount Per Security: KRW 437.5

Latest news about Precision Biosensor, Inc.

Qlife Signs Letter of Intent with Precision Biosensor	25/03	CI
Precision Biosensor, Inc. announced that it has received KRW 3 billion in funding from Shinhan Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd.	08/02	CI
Precision Biosensor, Inc. announced that it expects to receive KRW 3 billion in funding from Shinhan Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd. and another investor	06/02	CI
Precision Biosensor, Inc.(KOSDAQ:A335810) dropped from S&P Global BMI Index	19/22/19	CI
Precision Biosensor, Inc. announced that it has received KRW 150 billion in funding	18/21/18	CI
Precision Biosensor, Inc. announced that it expects to receive KRW 150 billion in funding	16/21/16	CI
Precision Biosensor, Inc.(KOSDAQ:A335810) added to S&P Global BMI Index	21/21/21	CI
Precision Biosensor, Inc. has completed an IPO in the amount of KRW 18.75 billion.	16/20/16	CI
Precision Biosensor, Inc. has filed an IPO.	23/20/23	CI

Chart Precision Biosensor, Inc.

Duration

Period

More charts

Company Profile

PrecisionBiosensor Inc is a Korea-based company mainly engaged in the development, manufacture and sale of in vitro diagnostic reagents. The Company's main products include testers and cartridges. The testers are portable immunoassay diagnostic devices for on-site diagnosis that uses colorimetric and time-resolved fluorescence to check acute heart disease, metabolism, and inflammatory diseases. The cartridges are used in gold absorption and time-resolved fluorescence analysis diagnostic equipment, and can check acute heart disease, metabolism, and inflammatory diseases. The Company sells its products in domestic and overseas markets such as Europe, China, the Middle East, and Southeast Asia.

Sector

Medical Equipment, Supplies & Distribution

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
PRECISION BIOSENSOR, INC.	-10.90%	36.16M
BIOMÉRIEUX	-4.92%	12.27B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-5.82%	7.99B
DIASORIN S.P.A.	+5.43%	5.69B
LANTHEUS HOLDINGS, INC.	+26.16%	5.42B
AUTOBIO DIAGNOSTICS CO., LTD.	-9.58%	4.13B
10X GENOMICS, INC.	-59.63%	2.7B
ANDON HEALTH CO., LTD.	+8.44%	2.6B
VITROLIFE AB	-3.70%	2.38B
MYRIAD GENETICS, INC.	+21.00%	2.1B

Diagnostic & Testing Substances